AU2015311677A1 - Systems and methods for determination of provenance - Google Patents
Systems and methods for determination of provenance Download PDFInfo
- Publication number
- AU2015311677A1 AU2015311677A1 AU2015311677A AU2015311677A AU2015311677A1 AU 2015311677 A1 AU2015311677 A1 AU 2015311677A1 AU 2015311677 A AU2015311677 A AU 2015311677A AU 2015311677 A AU2015311677 A AU 2015311677A AU 2015311677 A1 AU2015311677 A1 AU 2015311677A1
- Authority
- AU
- Australia
- Prior art keywords
- idiosyncratic
- predetermined
- markers
- marker profile
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 71
- 239000003550 marker Substances 0.000 claims abstract description 114
- 241000124008 Mammalia Species 0.000 claims description 50
- 210000001519 tissue Anatomy 0.000 claims description 47
- 238000004458 analytical method Methods 0.000 claims description 39
- 201000010099 disease Diseases 0.000 claims description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 33
- 108700028369 Alleles Proteins 0.000 claims description 12
- 230000004049 epigenetic modification Effects 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 108091008146 restriction endonucleases Proteins 0.000 claims description 10
- 108091081062 Repeated sequence (DNA) Proteins 0.000 claims description 9
- 210000000349 chromosome Anatomy 0.000 claims description 8
- 230000020509 sex determination Effects 0.000 claims description 7
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 210000001766 X chromosome Anatomy 0.000 claims description 3
- 210000002593 Y chromosome Anatomy 0.000 claims description 3
- 208000036878 aneuploidy Diseases 0.000 claims description 3
- 231100001075 aneuploidy Toxicity 0.000 claims description 3
- 210000003765 sex chromosome Anatomy 0.000 claims description 3
- 238000011331 genomic analysis Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 49
- 238000011160 research Methods 0.000 description 8
- 210000000601 blood cell Anatomy 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 208000017924 Klinefelter Syndrome Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 108091092878 Microsatellite Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 238000010205 computational analysis Methods 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000000126 in silico method Methods 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 108091023043 Alu Element Proteins 0.000 description 1
- 108091029523 CpG island Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 208000026928 Turner syndrome Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000007482 whole exome sequencing Methods 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Theoretical Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462046737P | 2014-09-05 | 2014-09-05 | |
| US62/046,737 | 2014-09-05 | ||
| PCT/US2015/048690 WO2016037134A1 (en) | 2014-09-05 | 2015-09-04 | Systems and methods for determination of provenance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2015311677A1 true AU2015311677A1 (en) | 2017-04-27 |
Family
ID=55437733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015311677A Withdrawn AU2015311677A1 (en) | 2014-09-05 | 2015-09-04 | Systems and methods for determination of provenance |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160070855A1 (https=) |
| EP (1) | EP3189457A4 (https=) |
| JP (1) | JP2017532699A (https=) |
| KR (1) | KR20170126846A (https=) |
| CN (1) | CN107735787A (https=) |
| AU (1) | AU2015311677A1 (https=) |
| CA (1) | CA2963785A1 (https=) |
| WO (1) | WO2016037134A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
| CA3014292A1 (en) | 2016-02-12 | 2017-08-17 | Regeneron Pharmaceuticals, Inc. | Methods and systems for detection of abnormal karyotypes |
| US10445099B2 (en) | 2016-04-19 | 2019-10-15 | Xiaolin Wang | Reconfigurable microprocessor hardware architecture |
| SG11201908893UA (en) * | 2017-03-29 | 2019-10-30 | Nantomics Llc | Signature-hash for multi-sequence files |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004516455A (ja) * | 2000-07-21 | 2004-06-03 | アプレラ コーポレイション | 生物学的データを評価するための方法、システム、および製品 |
| US20040175700A1 (en) * | 2002-05-15 | 2004-09-09 | Elixir Pharmaceuticals, Inc. | Method for cohort selection |
| US20040101903A1 (en) * | 2002-11-27 | 2004-05-27 | International Business Machines Corporation | Method and apparatus for sequence annotation |
| US8271201B2 (en) | 2006-08-11 | 2012-09-18 | University Of Tennesee Research Foundation | Methods of associating an unknown biological specimen with a family |
| US8069044B1 (en) * | 2007-03-16 | 2011-11-29 | Adobe Systems Incorporated | Content matching using phoneme comparison and scoring |
| CN102326080B (zh) * | 2009-02-20 | 2015-08-05 | 加利福尼亚大学董事会 | A+生物标志物的试验 |
| WO2010129793A1 (en) * | 2009-05-06 | 2010-11-11 | Ibis Biosciences, Inc. | Methods for rapid forensic dna analysis |
| EP2789693B1 (en) * | 2009-08-13 | 2017-10-04 | Life Technologies Corporation | Amelogenin SNP on chromosome X |
| KR101400303B1 (ko) * | 2009-08-25 | 2014-06-10 | 울산대학교 산학협력단 | 성별 판별용 ｓｎｐ 마커 |
| EP2504433B1 (en) * | 2009-11-25 | 2014-10-29 | Life Technologies Corporation | Allelic ladder loci |
| US9646134B2 (en) * | 2010-05-25 | 2017-05-09 | The Regents Of The University Of California | Bambam: parallel comparative analysis of high-throughput sequencing data |
| CN101894211B (zh) * | 2010-06-30 | 2012-08-22 | 深圳华大基因科技有限公司 | 一种基因注释方法和系统 |
| US9938575B2 (en) * | 2010-08-06 | 2018-04-10 | Rutgers, The State University Of New Jersey | Compositions and methods for high-throughput nucleic acid analysis and quality control |
| CN111192634A (zh) * | 2011-01-19 | 2020-05-22 | 皇家飞利浦电子股份有限公司 | 用于处理基因组数据的方法 |
| CA2887907A1 (en) * | 2011-10-31 | 2013-05-10 | The Scripps Research Institute | Systems and methods for genomic annotation and distributed variant interpretation |
| WO2014085826A2 (en) * | 2012-11-30 | 2014-06-05 | Applied Proteomics, Inc. | Method for evaluation of presence of or risk of colon tumors |
-
2015
- 2015-09-04 AU AU2015311677A patent/AU2015311677A1/en not_active Withdrawn
- 2015-09-04 WO PCT/US2015/048690 patent/WO2016037134A1/en not_active Ceased
- 2015-09-04 CN CN201580060142.XA patent/CN107735787A/zh active Pending
- 2015-09-04 US US14/846,290 patent/US20160070855A1/en not_active Abandoned
- 2015-09-04 EP EP15838553.4A patent/EP3189457A4/en not_active Withdrawn
- 2015-09-04 CA CA2963785A patent/CA2963785A1/en not_active Withdrawn
- 2015-09-04 JP JP2017531989A patent/JP2017532699A/ja not_active Withdrawn
- 2015-09-04 KR KR1020177009265A patent/KR20170126846A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2963785A1 (en) | 2016-03-10 |
| JP2017532699A (ja) | 2017-11-02 |
| EP3189457A4 (en) | 2018-04-11 |
| KR20170126846A (ko) | 2017-11-20 |
| CN107735787A (zh) | 2018-02-23 |
| EP3189457A1 (en) | 2017-07-12 |
| US20160070855A1 (en) | 2016-03-10 |
| WO2016037134A1 (en) | 2016-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clark et al. | Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas | |
| US20250333797A1 (en) | Normalizing tumor mutation burden | |
| Tran et al. | Objective and comprehensive evaluation of bisulfite short read mapping tools | |
| US20240296912A1 (en) | Methods for processing next-generation sequencing genomic data | |
| CN118910253A (zh) | 与癌症相关的基因融合体和基因变异体 | |
| AU2016293025A1 (en) | System and methodology for the analysis of genomic data obtained from a subject | |
| KR101945093B1 (ko) | 다중 종양 및 생식세포 유전자 엑솜에 걸친 분자 프로파일의 종합 분석을 위한 시스템 및 방법 | |
| WO2015149034A9 (en) | Gene fusions and gene variants associated with cancer | |
| US20190362807A1 (en) | Genomic variant ranking system for clinical trial matching | |
| Wilson et al. | scSNV: accurate dscRNA-seq SNV co-expression analysis using duplicate tag collapsing | |
| US20160070855A1 (en) | Systems And Methods For Determination Of Provenance | |
| JP2019003667A (ja) | がん遺伝子変異の機能確認におけるｒｎａ解析のためのシステムおよび方法 | |
| Kechin et al. | BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes | |
| US20180293348A1 (en) | Signature-hash for multi-sequence files | |
| Kendall et al. | Computational methods for DNA copy-number analysis of tumors | |
| US20190311779A1 (en) | Methods for detecting variants in next-generation sequencing genomic data | |
| Hiemenz et al. | Building a robust tumor profiling program: synergy between next-generation sequencing and targeted single-gene testing | |
| CN110475874A (zh) | 脱靶序列在dna分析中的应用 | |
| Hsu et al. | A mpli V ar: Mutation Detection in High‐Throughput Sequence from Amplicon‐Based Libraries | |
| Church | Next-generation sequencing | |
| Shen et al. | FirstSV: Fast and Accurate Approach of Structural Variations Detection for Short DNA fragments | |
| Mosen-Ansorena | Identification of mutated cancer driver genes in unpaired RNA-Seq samples | |
| Renaud et al. | trieFinder: an efficient program for annotating Digital Gene Expression (DGE) tags | |
| Papenfuss et al. | Bioinformatics Analysis of Sequence Data |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK12 | Application lapsed section 141(1)/reg 8.3(2) - applicant filed a written notice of withdrawal |